Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Treasury Shares (2016 - 2025)

Medifast's Treasury Shares history spans 11 years, with the latest figure at $6.4 million for Q4 2022.

  • For Q4 2022, Treasury Shares changed N/A year-over-year to $6.4 million; the TTM value through Dec 2022 reached $6.4 million, changed N/A, while the annual FY2022 figure was $6.4 million, N/A changed from the prior year.
  • Treasury Shares reached $677000.0 in Q4 2025 per MED's latest filing, down from $714000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $722000.0 in Q2 2025 to a low of $5000.0 in Q2 2021.
  • Average Treasury Shares over 5 years is $251388.9, with a median of $115000.0 recorded in 2023.
  • Peak YoY movement for Treasury Shares: soared 4017.2% in 2019, then tumbled 92.19% in 2020.
  • A 5-year view of Treasury Shares shows it stood at $30.9 million in 2018, then surged by 107.24% to $64.0 million in 2019, then crashed by 92.19% to $5.0 million in 2020, then crashed by 73.06% to $1.3 million in 2021, then soared by 374.98% to $6.4 million in 2022.
  • Per Business Quant, the three most recent readings for MED's Treasury Shares are $6.4 million (Q4 2022), $1.3 million (Q2 2021), and $12.5 million (Q1 2021).